Citation Impact

Citing Papers

Docetaxel Nanotechnology in Anticancer Therapy
2012
Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity
2017
Towards mild metal-catalyzed C–H bond activation
2011 Standout
Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy
2002
Quinoxaline, its derivatives and applications: A State of the Art review
2014 Standout
Laulimalide and Paclitaxel: A Comparison of Their Effects on Tubulin Assembly and Their Synergistic Action When Present Simultaneously
2004
Niemann-Pick disease type C
2010 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
A pH‐sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate
2008
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Marine natural products
1990 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
2012
Hydrophilic interaction liquid chromatography–APCI–mass spectrometry determination of 5-fluorouracil in plasma and tissues
2005
Block copolymer micelles: preparation, characterization and application in drug delivery
2005 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Indole synthesis: a review and proposed classification
2011 Standout
Polyether–polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations
2002
Kindlin-2 controls sensitivity of prostate cancer cells to cisplatin-induced cell death
2010
Hydrophilic interaction chromatography
2006 Standout
Physicochemical Stability of Monoclonal Antibodies: A Review
2019
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer
2005
Palladium‐Catalyzed Oxidative Cyclization of N‐Aryl Enamines: From Anilines to Indoles
2008
On the Importance of an Acid Additive in the Synthesis of Pyrido[1,2‐a]benzimidazoles by Direct Copper‐Catalyzed Amination
2011
Analysis of anticancer drugs: A review
2011 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Camptothecin and Podophyllotoxin Derivatives
2006
Topotecan and Etoposide in the Treatment of Relapsed High-risk Neuroblastoma
2007
Cisplatin: The first metal based anticancer drug
2019 Standout
Preparation, Characterization, and Stability of Liposome-Based Formulations of Mitoxantrone
2005
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Natural compounds for cancer treatment and prevention
2009 Standout
Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy
2002
Cancer-related inflammation and treatment effectiveness
2014 Standout
End-to-end design of wearable sensors
2022 Standout
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
ROS and the DNA damage response in cancer
2018 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
South African Salvia species: A review of biological activities and phytochemistry
2008
3d Transition Metals for C–H Activation
2018 Standout
Constituents from Salvia Species and Their Biological Activities
2012 Standout
Raman Spectroscopy of Biological Tissues
2007 Standout
The Potential of Cyclodextrins as Novel Active Pharmaceutical Ingredients: A Short Overview
2016
Fundamentals of cancer metabolism
2016 Standout
Mild metal-catalyzed C–H activation: examples and concepts
2016 Standout
Analysis of 5‐fluorouracil in saliva using surface‐enhanced Raman spectroscopy
2004
Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves
2010 StandoutNobel
Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells
2010
Recent Advances in Protection against Doxorubicin-induced Toxicity
2008
Gold(I)‐Catalyzed Cascade for Synthesis of Pyrrolo[1,2‐a:2′,1′‐c]‐/Pyrido[2,1‐c]pyrrolo[1,2‐a]quinoxalinones
2010
Structure−Activity Relationships of Highly Cytotoxic Copper(II) Complexes with Modified Indolo[3,2-c]quinoline Ligands
2010
Palladium‐katalysierte oxidative Cyclisierung von N‐Aryl‐Enaminen: von Anilinen zu Indolen
2008
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Synthesis of imidazo[1,2-a]pyridines: a decade update
2014 Standout
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
2014
Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box
2015 Standout
Aplidiopsamine A, an Antiplasmodial Alkaloid from the Temperate Australian Ascidian, Aplidiopsis confluata
2010
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Gold-Catalyzed Carbon−Heteroatom Bond-Forming Reactions
2011 Standout
Transition Metal-Catalyzed C–H Amination: Scope, Mechanism, and Applications
2017 Standout
Pyrrole Synthesis via Allylic sp3 C−H Activation of Enamines Followed by Intermolecular Coupling with Unactivated Alkynes
2010 Standout
Transition metal complexes of thiosemicarbazones with quinoxaline hub: an emphasis on antidiabetic property
2011

Works of Frédéric Pinguet being referenced

Effect of sodium chloride concentration and temperature on melphalan stability during storage and use.
1994
In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-β-cyclodextrin
1998
Population pharmacokinetics of topotecan: intraindividual variability in total drug
2000
Gemcitabine and docetaxel as front‐line chemotherapy in patients with carcinoma of an unknown primary site
2004
Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid
1999
Antiproliferative effect of methyl-β-cyclodextrin in vitro and in human tumour xenografted athymic nude mice
1998
Guidelines for the practical stability studies of anticancer drugs: A European consensus conference
2011
High-performance liquid chromatographic assay for melphalan in human plasma Application to pharmacokinetic studies
1996
Metabolism and Pharmacokinetics of EAPB0203 and EAPB0503, Two Imidazoquinoxaline Compounds Previously Shown to Have Antitumoral Activity on Melanoma and T-Lymphomas
2010
In vitro and in vivo anti-tumoral activities of imidazo[1,2-a]quinoxaline, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline derivatives
2008
High-performance liquid chromatographic assay for methyl-β-cyclodextrin in plasma and cell lysate
1997
Biodistribution of doxorubicin-alkylated poly(l-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration
2007
New imidazo[1,2-a]quinoxaline derivatives: Synthesis and in vitro activity against human melanoma
2009
Synthesis and Biological Evaluation of Indoloquinolines and Pyridocarbazoles: A New Example of Unexpected Photoreduction Accompanying Photocyclization
2007
Individual adaptive dosing of topotecan in ovarian cancer.
2002
Effect of mitoxantrone liposomes on multidrug-resistant breast cancer cells.
2000
Quantitation of imidazo[1,2‐a]quinoxaline derivatives in human and rat plasma using LC/ESI‐MS
2009
Docetaxel and Cisplatin in Patients With Metastatic Androgen Independent Prostate Cancer and Circulating Neuroendocrine Markers
2007
Combination paclitaxel and vinorelbine therapy: in vitro cytotoxic interactions and dose-escalation study in breast cancer patients previously exposed to anthracyclines.
1999
Stability of dacarbazine in amber glass vials and polyvinyl chloride bags
2002
Synthesis and in Vitro Cytotoxic Evaluation of New Derivatives of Pyrido[1,2-a]benzimidazolic Ring System: The Pyrido[1',2':1,2]imidazo[4,5-h]quinazolines.
2001
A Photochemical Approach to Pyridopyrroloquinoline Derivatives as New Potential Anticancer Agents
2004
In vitro schedule-dependent interaction between paclitaxel and vinorelbine in A2780 parental and multidrug-resistant human ovarian cancer cell lines
1997
In vitroCytotoxic Activity of Three Essential Oils fromSalviaSpecies
1999
Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation.
1997
Determination of 5-fluorouracil and its main metabolites in plasma by high-performance liquid chromatography: Application to a pharmacokinetic study
1997
Rankless by CCL
2026